Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-(5-amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid is a synthetic small molecule belonging to the aminobenzoic acid derivatives class. It features a benzoic acid core with an azo-linked pyrazole moiety containing amino and imino substituents. The compound is primarily of research interest and has been identified as targeting methionine aminopeptidase, an enzyme involved in protein processing. Its mechanism of action is presumed to involve inhibition or modulation of this enzyme, but it remains experimental with no established clinical use or approved therapeutic indications[2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-(5-amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid.